Gara Jalqabaatti › Kansa Selii Skwaamoo Mataa fi Morma › Wisconsin › Milwaukee
Qorannoo klinikaalii Kansa Selii Skwaamoo Mataa fi Morma Milwaukee, WI keessatti
Qorannoo 13 Kansa Selii Skwaamoo Mataa fi Morma f Milwaukee fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- fi 8 dabalataa
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Namoota walitti qabaa jiraSadarkaa 2/3
- Site # 0153, Milwaukee
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #33, Milwaukee
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Namoota walitti qabaa jiraSadarkaa 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- fi 8 dabalataa
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Milwaukee
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
- ProHealth Waukesha Memorial Hospital, Waukesha · Miili 17 fagaatti
- UW Cancer Center at ProHealth Care, Waukesha · Miili 17 fagaatti
- fi 1 dabalataa
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · Miili 11 fagaatti
- Froedtert Menomonee Falls Hospital, Menomonee Falls · Miili 14 fagaatti
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Froedtert & MCW Cancer Center, Milwaukee
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Namoota walitti qabaa jiraSadarkaa 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- fi 5 dabalataa
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · Miili 11 fagaatti
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · Miili 11 fagaatti
- fi 1 dabalataa
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Medical College of Wisconsin, Milwaukee
- Zablocki Veterans Administration Medical Center, Milwaukee
- Drexel Town Square Health Center, Oak Creek · Miili 11 fagaatti
- fi 1 dabalataa
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Namoota walitti qabaa jiraSadarkaa 3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · Miili 11 fagaatti
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · Miili 11 fagaatti
- fi 1 dabalataa
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Froedtert & the Medical College of Wisconsin, Milwaukee
Qorannoo Kansa Selii Skwaamoo Mataa fi Morma magaalota biroo keessatti
- Houston, TXQorannoo 47
- Los Angeles, CAQorannoo 42
- Boston, MAQorannoo 40
- New York City, NYQorannoo 39
- Nashville, TNQorannoo 39
- St. Louis, MOQorannoo 28
- Arlington, VAQorannoo 26
- Philadelphia, PAQorannoo 26
- Chicago, ILQorannoo 26
- Atlanta, GAQorannoo 24
- San Antonio, TXQorannoo 22
- New Haven, CTQorannoo 22
Qorannoo biroo Milwaukee keessatti
- Saree OljooQorannoo 23
- Saree (Gosoota Hunda)Qorannoo 22
- Kansara Qara'a Non-Small CellQorannoo 22
- Myeloma Baay’eeQorannoo 21
- Dhibee QaraQorannoo 21
- Kansarii ProstateQorannoo 20
- Lymphoma FollicularQorannoo 19
- Non-Hodgkin LymphomaQorannoo 18
- Kansarii PancreasQorannoo 18
- Leukemia Myeloidii HamaaQorannoo 17
- Kansarii OvariiQorannoo 17
- Diffuse Large B-Cell LymphomaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.